GoodRx Holdings, Inc. announced the results of its 2026 Annual Meeting of Stockholders held on June 16, 2026. Shareholders voted to approve all proposals, including the election of three Class III directors, the ratification of the company's independent auditor, and the non-binding approval of executive compensation.
Key Details
- Director Elections: Wendy Barnes, Ronald E. Bruehlman, and Gregory Mondre were elected as Class III directors for a three-year term expiring at the 2029 annual meeting.
- Auditor Ratification: The appointment of KPMG LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified.
- Executive Compensation: Stockholders approved, on a non-binding advisory basis, the compensation of the company's named executive officers.
- Voter Turnout: Approximately 99.4% of the combined voting power of the company’s Class A and Class B common stock was represented at the meeting.